Compared with chemical synthesis, fermentation has the advantage of mass production at low cost, and has been used in the production of various industrial chemicals. As a valuable organic compound, 1,3-propanediol (1,3-PDO) has numerous applications in the production of polymers, lubricants, cosmetics and medicines. Here, conversion of glycerol (a renewable substrate and waste from biodiesel production) to 1,3-PDO by E. coli bacterial strain carrying altered glycerol metabolic pathway was investigated. Two gene constructs containing the 1,3-PDO operon from Citrobacter freundii (pCF1 and pCF2) were used to transform the bacteria. The pCF1 gene expression construct contained dhaBCE genes encoding the three subunits of glycerol dehydratase, dhaF encoding the large subunit of the glycerol dehydratase reactivation factor and dhaG encoding the small subunit of the glycerol dehydratase reactivating factor. The pCF2 gene expression construct contained the dhaT gene encoding the 1,3-propanediol dehydrogenase. Expression of the genes cloned in the above constructs was under regulation of the T7lac promoter. RT-PCR, SDS-PAGE analyses and functional tests confirmed that 1,3-PDO synthesis pathway genes were expressed at the RNA and protein levels, and worked flawlessly in the heterologous host. In a batch flask culture, in a short time applied just to identify the 1,3-PDO in a preliminary study, the recombinant E. coli bacteria produced 1.53 g/L of 1,3-PDO, using 21.2 g/L of glycerol in 72 h. In the Sartorius Biostat B Plus reactor, they produced 11.7 g/L of 1,3-PDO using 24.2 g/L of glycerol, attaining an efficiency of 0.58 [mol 1,3-PDO /mol glycerol ].
INTRODUCTION
1,3-Propanediol (1,3-PDO), a trimethylene glycol, is an organic compound belonging to the diol group, with a molecular formula of C 3 H 8 O 2 , molar mass of 76.09 g/ mol and density of 1.0597 g/cm 3 . Under normal conditions it is a colorless liquid, miscible with water. 1,3-PDO exhibits many valuable properties, thanks to which it has been applied for years in various branches of industry (Igari et al., 2000) . 1,3-PDO is mainly used in the chemical industry as a monomer in the synthesis of biodegradable polyesters, polyurethanes and polyethers providing them with greater strength, while it is also contained in various products in the cosmetics, textile and medical industries. This compound provides specific properties to solvents, resins, laminates, and detergents (Menzel et al., 1997; Zeng & Biebl, 2002; Zhu et al., 2002; Cheng et al., 2007; Sauer et al., 2008) . A breakthrough in the use of 1,3-PDO was connected with the British-Dutch petrochemical consortium (Shell) commercialization in 1995 of a novel aromatic polyester, Corterra ® PTT polytrimethylene terephthalate, based on 1,3-PDO (Shell Chemical Company, Press release, 1995) . This polymer has greater strength properties, greater tensile strength and elasticity than polyester based on ethylene or butylene glycol or 1,2-propanediol (1,2-PDO) (Chuah et al., 1995; Kurian 2005; Liu et al., 2010) . It is used as fiber to produce yarn in the manufacturing of textiles and carpets (Chuah, 1996; Brown & Chuah, 1997) . In 2000, DuPont commercialized polytrimethylene terephthalate Sorona®, based on 1,3-propanediol obtained in the fermentation process (Chotani et al., 2000; EMBO reports, 2003; Nakamura & Whited, 2003) . It was one of the first global achievements on the biotech market which used a genetically modified E. coli strain K-12 and a renewable energy source, i.e. corn glucose. 1,3-PDO is produced mainly by chemical methods, although this compound may be produced using microorganisms in the fermentation of various carbon sources, e.g. glycerol. Pure glycerol does not pose a hazard and it is used in various branches of industry, while glycerol from the production of biofuel, containing numerous contaminants, is a noxious waste (Dharmadi et al., 2006) . Purification of waste glycerol is unprofitable, while its potential conversion to a valuable compound solves the problem of its troublesome management. Production of 1,3-PDO from waste glycerol is a cheaper method than chemical production of this compound (Rehman et al., 2008) . The findings of studies on the effect of waste glycerol on bacterial growth and the production of 1,3-PDO prove that there is no significant difference in comparison to pure glycerol (Papanikolaou et al., 2004) . It has been known for over 120 years that 1,3-PDO is one of the products formed during microbial fermentation of glycerol. This molecule was identified for the first time in 1881 by the chemist August Freund as a product of glycerol fermentation run by Clostridium pasteurianum (Nakas et al., 1983; Biebl et al., 1999) . In the last two decades, advances have been observed in biological production methods of 1,3-PDO from cheap, renewable energy sources, applying newly developed strains to produce 1,3-PDO (Deckwer, 1995; Zhu et al., 2002) . The physiological role of 1,3-PDO synthesis in glycerol metabolism concerns regeneration of the NAD + coenzyme from the reduced form obtained via the oxidative pathway, in which glycerol is first oxidized to dihydroxyacetone (DHA), which is followed by phosphorylation and formation of phosphodihydroxyacetone (DHAP), which is subsequently transformed into pyruvate (Forage & Lin, 1982; Zhu et al., 2002) . There are natural producers of 1,3-PDO, as well as heterologous hosts of the 1,3-PDO synthesis pathway (Homann et al., 1990; GonzalezPajuelo et al., 2006) . Both, the former and the latter, are used in studies on the production of 1,3-PDO. Natural producers of 1,3-PDO include bacteria from the Klebsiella (Huang et al., 2002; Németh et al., 2003) , Citrobacter (Boenigk et al., 1993; Seifert et al., 2001) , Clostridia (Colin et al., 2001; Malaoui & Marczak, 2001) , Enterobacter (Zhu et al., 2002) and Lactobacilli genera (Schutz & Radler, 1984) . The species most often described in the literature on this subject include for e.g. Citrobacter freundii (Malinowski, 1999) , Klebsiella pneumoniae (Biebl et al., 1998) , Clostridium pasteurianum (Biebl, 2001) , Clostridium butyricum (Papanikolaou et al., 2004) , Lactobacillus brevis and Lactobacillus buchnerii (Schutz & Radler, 1984) , whose glycerol metabolic pathway contains a branch in which 1,3-PDO is formed in the fermentation process. Most natural 1,3-PDO producers metabolize glycerol via two pathways: reductive and oxidative (Zhu et al., 2002) (Fig. 1) . 1,3-PDO is formed in the reductive pathway. In the first stage of the reductive pathway, glycerol is dehydrated by glycerol dehydratase (GDHt, dhaBCE genes) in the presence of coenzyme B 12 , with the formation of 3-hydroxypropionaldehyde (3-HPA) (Knietsch et al., 2003) . Next, NADH + H + -dependent 1,3-PDO dehydrogenase (1,3-PD DH, PDOR-oxidoreductase 1,3-PDO, dhaT gene) reduces 3-HPA to 1,3-PDO, regenerating NAD + (Ahrens et al., 1998; Skraly et al., 1998) . In the oxidative pathway, NAD + -dependent glycerol dehydrogenase (GDH) catalyzes oxidation of glycerol to dihydroxyacetone (DHA), which is then phosphorylated in the presence of the glycolytic enzyme ATP-dependent dihydroxyacetone kinase (DHAK) (Forage & Lin, 1982; Daniel et al., 1995a) . Reduced coenzymes formed in the oxidative pathway are necessary for the execution of reductive pathways, in which 1,3-PDO is synthesized, as well as the other products of glycerol metabolism. In our work, a strain from the Citrobacter genera was a donor of heterologous genes. This microorganism belongs to a species efficiently producing 1,3-PDO from glycerol; however, it is classified as a microbial hazard group II, which limits its potential application in industrial processes. The application of E. coli (as a heterologous host) in biotechnological processes is becoming increasingly desirable (also in the 1,3-PDO production) as an alternative to using "natural producers". Molecular cloning and expression of genes encoding GDHt and 1,3-PD DH from C. freundii had been reported (Daniel & Gottschalk, 1992; Daniel et al., 1995a; Daniel et al., 1995b; Seyfried et al., 1996; Seifert et al., 2001; Qi et al., 2013) , but studies on 1,3-PDO production by E. coli containing C. freundii 1,3-PDO operon genes are still limited. Production of 1,3-PDO both from glucose and glycerol, using a native strain of E. coli, is based on a completely heterologous pathway . Due to the lack of the dha regulon (which is present in the 1,3-PDO producers) E. coli cannot ferment glycerol to 1,3-PDO. Instead, 1,2-PDO and ethanol are produced (Fig. 2) . The aim of this study was to engineer a modified E. coli capable of producing 1,3-PDO from glycerol as a substrate. This aim was achieved by designing and making gene expression constructs carrying a total of six heterologous genes participating in glycerol catabolism and originating from C. freundii. The next stages in carrying out of this study included introduction of these constructs into E. coli cells and performing molecular and metabolic analyses of the recombinant strain, confirming the functioning of the incorporated heterologous genes in E. coli.
MATERIALS AND METHODS

Strains and plasmids.
The genes for the production of 1,3-PDO in E. coli were cloned into the pET-22b(+) (Novagen) and pET-26b(+) (Novagen) expression vectors and sequenced. Genomic DNA from Citrobacter freundii ATCC 8090 (American Type Culture Collection, Manassas, VA 20108 USA) was the gene source for cloning experiments. E. coli BL21(DE3)pLysS and Rosetta 2(DE3)pLysS strains (Novagen) were used as hosts for gene expression experiments.
Media and growth conditions. E. coli was grown in the LB medium supplemented with ampicillin (100 µg/ml), chloramphenicol (34 µg/ml) and/or kanamycin (50 µg/ml). In the first (24-hour) and the second (72-hour) experiment, bacteria were cultured in six flasks, with flasks no. 1-3 initially containing 4 g/L of pure glycerol (anhydrous glycerol POCH S.A.), and flasks no. 4-6 containing 70 g/L. The culture medium in flasks no. 1, 2, 4, and 5 was inoculated with 3 ml of recombinant E. coli BL21(DE3)pLysS culture (with pCF1 and pCF2 gene constructs), while 3 ml of non-recombinant Pyruvate is reduced to different organic compounds depending on the microorganism. GDHt, glycerol dehydratase; 1,3-PDDH, 1,3-propandiol dehydrogenase; GDH, glycerol dehydrogenase; DHAK, dihydroxyacetone kinase. The figure was prepared based on (Biebl, 2001 ). 1,3-Propanediol production by Escherichia coli E. coli BL21(DE3)pLysS culture were transferred into flasks 3 and 6. Subsequently, in the logarithmic growth phase (OD 600 ≈ 0.6-0.8), the IPTG inducer was added to flasks no. 1 and 4, to a final concentration of 1mM. Cultures were maintained at 37°C, 160 rpm, without pH adjustment. Subsequently, after 24 and 72 hours, glycerol and 1,3-PDO concentrations in the production medium were determined by high-performance liquid chromatography (HPLC). Third batch fermentation was performed in a 5 L bioreactor (Sartorius Stedim Poland) integrated with the inoculum jar (Duran), a bottle of 20% NaOH and a distilled water bottle, which enables control of the correct gas flow through the system. A total of 0.4 vvm of air was sparged into the broth to maintain microaerobic conditions. The fermentation was carried out in two stages: the first was conducted to obtain highcell density, the other to carry out the main production process. Primary inoculum (4 ml) was transferred to the jar (proliferation medium with a total volume of 200 ml, 5 g/L yeast extract, 0.5 g/L NaCl, 0.48 g/L MgSO 4 • 7H 2 O, 11.3 g/L Na 2 HPO 4 • 7H 2 O, 3 g/L KH 2 PO 4 , 2 g/L NH 4 Cl, 100 µg/ml ampicillin, 50 µg/ml kanamycin, 34 µg/ml chloramphenicol) integrated with the bioreactor. The jar was placed in a water bath (37°C), and incubated for 24 h. Following this, the contents of the jar were pumped into the bioreactor. Initially, the production medium contained no glycerol (final volume of 2 L, the medium composition differed from the composition of the proliferation medium by the absence of glucose, the presence of vitamin B 12 in a concentration of 1.5 mM and IPTG added in the bacteria logarithmic growth phase to a final concentration of 1 mM). After 24 h, pure glycerol was added to a final concentration of 35 g/L. Fermentation proceeded for 168 h. The pH was controlled at 7.0, the growth temperature was 37°C, and agitation at 60 rpm was maintained.
Construction of recombinant plasmids. The pCF1 construct contained dhaBCE, dhaF, dhaG genes from C. freundii ATCC 8090 inserted under the control of the T7lac promoter in the pET-22b(+) expression vector (Fig. 3 ). This construct was prepared by the following steps: 1) The dhaBCE genes were amplified using genomic DNA of C. freundii ATCC 8090 as the template with primers F (5'-CGACATATGAGAAGAT-CAAAACGATTCGAA-3') and R (5'-CCCGTCGACT-CACTGGCTGCCTTTACGCAGCTTATTTC-3'). The 5' end of the fragment was modified by the addition of a NdeI restriction site, while at the 3' end, a SalI restriction site was introduced. PCR products were digested with restriction enzymes (NdeI and SalI) and cloned into a pET-22b(+) expression vector within NdeI and SalI restriction sites.
2) The sequence encoding dhaF gene was amplified by PCR using the same template and primers F (5'-TTTGTCGACCGGAGGCAGCATGCCGTTA-ATTGCAGGGATCGATATC-3') and R (5'-TTTA-AGCTTCTATTTTTTTGCATCTCCGGCTAAAAC-
Figure 2. Glycerol metabolism in a wild-type Escherichia coli strain.
Branch from glycerol to DHAP via glycerol-3-phosphate occurs in the presence of external electron acceptors. GlyDH-II, glycerol dehydrogenase; DHAK, dihydroxyacetone kinase; GK, glycerol kinase; G-3-PDH, glycerol-3-phosphate dehydrogenase; TPI, triosephosphate isomerase; MGS, methylglyoxal synthase; AOR, aldehyde oxidoreductase; 1,2-PDOR, 1,2-propandiol reductase; MGR, methylglyoxal reductase; Glx-I, glyoxalase type I; Glx-II, glyoxalase type II; Glx-III, glyoxylase type III; LALDH, lactaldehyde dehydrogenase; FRD, fumarate reductase; PYK, pyruvate kinase; LDH, lactate dehydrogenase; PFL, pyruvate formate lyase; FHL, formate hydrogen lyase; ADH, alcohol dehydrogenase; PTA, phosphate acetyltransferase; ACK, acetate kinase; DHA, dihydroxyacetone; G3P, glycerol-3-phosphate; DHAP, dihydroxyacetone phosphate; GAL3P, glyceraldehyde-3-phosphate; HA, hydroxyacetone; MG, methylglyoxal; 1,2-PDO, 1,2-propandiol; LAL, lactaldehyde; PEP, phosphoenolpyruvate. The figure was prepared based on (Gonzalez et al., 2008; Clomburg & Gonzalez, 2010) .
CAG-3'). The 5' end of the gene was modified by the addition of a SalI restriction site and the RBS sequence (underlined). The 3' end of the gene was modified by the addition of a HindIII restriction site. PCR products were digested with restriction enzymes and ligated into the pET22b(+) construct containing the dhaBCE gene and cleaved by SalI and HindIII.
3) The fragment containing a dhaG gene was amplified using genomic DNA as the template and primers F (5'-TTTAAGCTTACAGG-GGGCGCAATGTCACTTTCATCACCGGG-3') and R (5'-TTTGCGGCCGCTTATTTTATCTCGCTGAAGG-GA-3'). The 5' end of the gene was modified by the addition of a HindIII restriction site and the RBS sequence (underlined), while at the 3' end a NotI restriction site was introduced. PCR products were digested with restriction enzymes HindIII and NotI and cloned into a plasmid containing dhaBCE and dhaF genes cleaved with the same enzymes.
The pCF2 construct contained a dhaT gene from C. freundii ATCC 8090 inserted under the control of T7lac promoter in the pET-26b(+) expression vector (Fig. 4) . The dhaT gene was amplified using genomic DNA of C. freundii ATCC 8090 as the template with primers F (5'-CGACATATGAGCTATCGTATGTTT-GATTA-3') and R (5'-TTCGAATTCAGAATGCCT-GACGGAAGAT-3'). The 5' end of the gene was modified by the addition of a NdeI restriction site, while at the 3' end, an EcoRI restriction site was introduced. PCR products were digested with restriction enzymes (NdeI and EcoRI) and cloned into a pET-26b(+) expression vector within NdeI and EcoRI restriction sites. All genes were sequenced using automated genetic analyzers (Applied Biosystems Prism). General procedures for manipulating DNA were carried out according to Sambrook et al. (2001) . Plasmid DNA was isolated by using StrataPrep Plasmid Miniprep Kit (Stratagene). PCR reagents, restriction enzymes and T4 DNA ligase were purchased from Sigma, Fermentas or New England Biolabs.
Overexpression, preparation of cell extracts and SDS/PAGE analysis. Single colonies of the E. coli BL21(DE3)pLysS and Rosetta 2(DE3)pLysS strains containing the expression plasmids pCF1 and pCF2 were inoculated into an LB broth containing ampicillin (100 µg/ml)/kanamycin (50 µg/ml) and chloramphenicol (34 µg/ml) and grown at 37°C to OD 600 ~0.6-0.8.
IPTG was added to the final concentration of 1 mM. Cells were harvested after a 5-hour induction and resuspended in 0.1 vol. of 50 mM sodium phosphate, pH 8.0, 300 mM NaCl, 8 M urea, and were then homogenized. Insoluble material was removed by centrifugation (10 000 rpm, 20 min at 4°C). Protein samples were separated by SDS-PAGE using 16% (w/v) SDS-polyacrylamide gel and identified by staining with Coomassie Brilliant Blue R-250 (Merck) (Fig. 5) . SDS/PAGE analysis was carried out by the Laemmli method (Laemmli, 1970) , with the use of a Mini-Protean3 Cell Electrophoresis System (BioRad). A protein molecular weight marker (Promega) was used to estimate the molecular masses of the proteins.
RNA isolation and RT-PCR analysis. Total RNA was prepared using a Total RNA Mini Plus kit as described by the manufacturer (A&A Biotechnology). The expression of the dhaBCE, dhaF, dhaG and dhaT genes was evaluated by RT-PCR. First strand cDNA synthesis was prepared by reverse transcription, using the SuperScript III First-Strand Synthesis System for RT-PCR (Invitrogen). Expression analysis was performed with the use of a PCR reaction with the total RNA matrix as a negative control to confirm the purity of RNA preparations. Gene constructs were used as a positive control. 
Primers used in the RT-PCR analysis are listed in Table 1 . High-performance liquid chromatography analysis of metabolites. The presence of 1,3-propanediol and glycerol was analyzed using an Agilent Technologies 1200 series high-performance liquid chromatography system with a refractive index detector G1362A and a Rezex ROA -Organic Acid H + (8%), 300×7.8 mm column, while maintaining the temperature of the column oven at 40°C. The mobile phase was 0.0025 mM H 2 SO 4 . The samples were introduced through an injector valve (10 µl volume), while maintaining the flow rate of 0.6 ml/min using an isocratic pump system. The liquid chromatography system was also equipped with the Bin Pump G1312B, Autosampler G1329B, Column Thermostat G1316A and Degasser G1379B. The retention times of 1,3-PDO and glycerol were 16.4 and 12.9, respectively. The quantitative and qualitative identification was carried out by an external standard using peak areas (for measurement and integration, the ChemStation for LC 3D Systems, Agilent was used).
RESULTS
Sequence analysis
In total, 6897 bp of the 1,3-PDO operon in the C. freundii ATCC 8090 strain was sequenced (GenBank HM032027). The nucleotide sequence of the 1,3-PDO operon in the analyzed strain was shown to be 92% homologous with the DSM30040 strain sequence available in the GenBank database (U09771). For amino acid sequences of specific genes, the homology was between 92% and 99%.
RT-PCR analysis
RT-PCR analysis was used to determine the expression of heterologous genes in E. coli BL21(DE3)pLysS cells. This analysis was performed for bacteria that underwent cotransformation with two gene expression constructs, i.e. pCF1 and pCF2, containing genes from C. freundii ATCC 8090. RT-PCR analysis revealed the expression of all heterologous genes. No specific PCR products were observed in the negative control reactions.
Overexpression of pCF1 and pCF2 constructs
Genes dhaBCE, dhaF and dhaG from the pCF1 construct, as well as the dhaT gene from pCF2, were all transcribed in the same direction and were under control of the T7lac promoter. The E. coli BL21(DE3)pLysS bacteria were transformed using the pCF1 gene construct. Protein overexpression was observed in cell extracts obtained from the bacteria after overnight culture and induction of expression with IPTG added in the logarithmic growth phase (OD 600 ≈ 0.6-0.8), followed by homogenization in a glass homogenizer. Protein samples were separated by SDS-PAGE using 16% (w/v) polyacrylamide gel, and stained with Coomassie Blue (Fig. 5 ). An analogous procedure was followed for the pCF2 construct. For the latter, kanamycin (50 µg/ml) was used as a selection factor.
The results of the experiment (Fig. 5 ) indicated efficient overexpression of the dhaT gene from C. freundii in E. coli. In the gel, no products of the genes contained in the pCF1 construct, i.e. the three subunits of glycerol dehydratase (dhaBCE) and the two subunits of the glycerol dehydratase reactivation factor (dhaF, dhaG) were observed. Their presence was, however, confirmed by a functional test (the conversion of glycerol to 1,3-PDO in batch fermentation). The expression of the genes at the mRNA level in E. coli BL21(DE3)pLys was confirmed by RT-PCR. To assess the expression of the other heterologous genes through protein electrophoresis separation in the next stage of the study, the E. coli Rosetta 2(DE3)pLysS strain was used. SDS/ PAGE analysis of the expression of products from genes inserted into the pCF1 construct indicated a higher level of the expressed protein in E. coli Rosetta 2(DE3)pLysS cells, compared to the E. coli BL21(DE3) pLysS strain. This was likely due to the presence of the plasmid equipping the bacterial cells with a set of tRNAs that are rare in E. coli.
Batch fermentation by the recombinant E. coli BL21(DE3)pLysS strain
After cotransformation of the E. coli BL21(DE3)pLysS strain cells with the pCF1 and pCF2 constructs, the presence of the introduced plasmids was verified via the PCR reaction with primers specific for the sequences encoding each enzyme. The E. coli BL21(DE3)pLysS colony, in which the presence of heterologous genes was confirmed, was used in culture tests. However, PCR vector stability analysis for E. coli BL21(DE3)pLysS confirmed that the bacteria could successfully be used after longterm storage at -80°C in 10% glycerol stock (Fig. 6) .
In the first (24-hour) experiment, 1,3-PDO was identified in flask no. 4 at a concentration of 1.23 g/L. In the second (72-hour) experiment, which differed from the first one in terms of culture time, 1,3-PDO was identified in flask no. 4 at the concentration of 1.53 g/L. In both experiments, in flasks no. 3 and 6 containing the non-recombinant E. coli strain (negative control), and in flasks no. 2 and 5 containing the recombinant strain with no IPTG inducer, no 1,3-PDO was observed; in flask no. 1, small amounts of 1,3-PDO were found. All results are shown in Tables 2 and 3 . The purpose of the bioreactor culture was to determine 1,3-PDO yield and the efficiency of 1,3-PDO synthesis from glycerol in a pH-controlled, nonoptimized culture. IPTG was added after 12 hours, and glycerol was added after 24 hours of culturing. In the Sartorius Biostat B Plus bioreactor, the recombinant strain containing gene constructs pCF1 Table 2 . 1,3-propanediol production in flask cultures of the E. coli BL21(DE3) pLysS strain with the pCF1 and pCF2 gene constructs comprising C. freundii 1,3-PDO operon genes. Results at 24 hours of culturing. Samples 1 and 4, recombinant E. coli BL21(DE3) pLysS strain induced with IPTG; 2 and 5, recombinant strain with no IPTG induction; 3 and 6, E. coli BL21(DE3)pLysS with no gene constructs (negative control). RT, retention time (min). (Table 4) .
DISCUSSION AND CONCLUSIONS
Demand for chemical raw materials, including 1,3-PDO, rises each year. Currently, 1,3-PDO (which is a substrate for polyurethane production) is obtained using chemical methods that have an adverse environmental impact and use non-renewable energy sources. PTT and polyurethanes produced from 1,3-PDO are widely used for e.g. in clothing and carpet manufacturing. Biotechnological synthesis of chemicals will gradually supersede the original method, as it is a novel approach enabling the use of renewable energy sources and waste substrates, taking advantage of the natural fermentation capabilities of bacterial strains.
Obtaining polyol from waste glycerol allows manufacturers to forgo the use of petroleum products for this purpose. Natural deposits are being gradually depleted, while demand from modern industry is growing exponentially. Hence, the importance of recuperation and recycling.
The purpose of the present study was to obtain, by means of genetic modification, E. coli bacteria capable of producing 1,3-PDO from glycerol. Native E. coli do not have a metabolic pathway for 1,3-PDO synthesis. Therefore, 1,3-PDO genes transferred from a donor (1,3-PDO producing) strain are fully heterologous for the microorganism. The main objectives of the study were to design and construct expression vectors and to insert them into the host cells, to enable 1,3-PDO production from glycerol.
The selection of E. coli bacteria for the 1,3-PDO production seems fully justified, since they are non-pathogenic, easy to culture and proliferate rapidly. E. coli bacteria are very convenient for these applications. For these reasons E. coli is one of the best prokaryotic systems for the production of valuable chemical compounds.
In this study, two gene expression constructs were generated, containing six heterologous genes of glycerol catabolism coming from C. freundii ATCC 8090. Selected genes belong to the reductive branch of glycerol dissimilation, which leads directly to the compound desired.
In C. freundii, 1,3-PDO operon genes, i.e. glycerol dehydratase (dhaBCE), the large subunit of the glycerol dehydratase reactivation factor, and 1,3-PDO dehydrogenase (dhaT), the small subunit of the glycerol dehydratase reactivation factor, are naturally controlled by two promoters and transcribed in opposite directions (Skraly et al., 1998; Seifert et al., 2001) .
The literature available does not contain reports concerning the modification of E. coli strains using operon genes coming from C. freundii ATCC 8090 strain. In our work we have also sequenced a 1,3-PDO operon of this strain. Sequence data were submitted to the GenBank database and assigned accession number HM032027.1.
Our gene expression constructs were designed so that one vector incorporated genes responsible for the first stage of conversion, while the second vector contained genes connected with the final stage of conversion, all transcribed in the same direction and located under the control of T7lac, which is a strong promoter, allowing efficient expression of the inserted genes (Ikeda et al., 1992) . This approach allows gene constructs from various organisms to be inserted interchangeably into the E. coli cells, so that combinations yielding the highest efficiencies of 1,3-PDO production could be found.
This study incorporated a transformant selection based on genes encoding resistance to antibiotics (ampicillin and kanamycin), carried by the pET-22b(+) and pET-26b(+)vectors, respectively. Thanks to the use of vectors with different antibiotic resistance genes, it was possible to simultaneously maintain two gene constructs carrying the complete reductive pathway in the E. coli cells.
In the section concerning the molecular characteristics of the recombinant E. coli BL21(DE3)pLysS strain, the expression of incorporated genes was analyzed at the mRNA and protein levels. Electrophoretic separation of proteins confirmed efficient expression of the dhaT gene in the E. coli BL21(DE3)pLysS cells. RT-PCR analysis has confirmed the expression of all the incorporated genes at the mRNA level. Since one of the causes of problems with observation of pCF1 encoded proteins may be the presence of rare codons for E. coli, the pCF1 construct was incorporated into the Rosetta 2 (DE3) pLysS strain. Such an approach made it possible to observe several proteins which may correspond to products of genes contained in pCF1, although the results were difficult to interpret due to the presence of E. coli endogenous proteins (data not shown). Difficulties in identifying particular proteins in polyacrylamide gel notwithstanding, the results of the bacterial cultivation part of the study (glycerol-to-1,3-PDO conversion in batch fermentation) indicated that all the required proteins were produced in the recombinant E. coli BL21(DE3)pLysS bacteria.
Construct stability analysis for E. coli BL21(DE3) pLysS cells, performed using a colony PCR reaction with primers specific for the heterologous genes present in the bacterial colony (containing constructs pCF1 and pCF2) known to convert glycerol to 1,3-PDO, aimed at proving that both gene constructs are maintained in E. coli cells after long-term storage. The results confirmed that antibiotic selection is a sufficiently effective method to maintain both gene constructs in E. coli cells after a longer storage time (9 months) (Fig. 6) . A necessary stage in carrying out of the aim assumed in this study was connected with sequencing 1,3-PDO operon from the donor strain ATCC 8090. The differences observed between the sequences of the donor strain and the DSM30040 strain described in the GenBank database may affect the efficiency of 1,3-PDO production, which may vary for different strains.
Metabolic analysis of the recombinant E. coli BL21(DE3)pLysS strain involved flask cultures (24 h and 72 h) with no pH adjustments, and a more controlled bioreactor culture, aiming to identify 1,3-PDO in the production medium and determine its concentration via HPLC. The main purpose of the metabolic analysis was to confirm the expected functioning of the constructs introduced into E. coli. The 1,3-PDO yield established should be considered a preliminary result. Culture optimization, which was not a part of the present study, could significantly enhance the efficiency of glycerolto-1,3-PDO conversion in the future.
In this study, batch fermentation was used, as the bacterial cultivation part of the study was designed to confirm the inserted genes' functionality. The results obtained (expression and cultures) indicate that the constructs were designed properly, as the expression of the heterologous genes enabled E. coli to produce 1,3-PDO, as opposed to the wild-type strain that has no such capabilities. This was confirmed with the flask experiments using a non-recombinant E. coli BL21(DE3)pLysS strain as a negative control.
In a batch flask culture, the recombinant E. coli bacteria produced 1.23 g/L of 1,3-PDO using 14.1 g/L of glycerol in 24 h, and 1.53 g/L of 1,3-PDO using 21.2 g/L of glycerol in 72 h. In the Sartorius Biostat B Plus reactor, they produced 11.7 g/L of 1,3-PDO using 24.2 g/L of glycerol, attaining an efficiency of 0.58 [mol 1,3-PDO /mol glycerol ] (Tables 2, 3, 4) . Variants currently in use also include microorganisms naturally producing 1,3-PDO (despite their invasiveness), while the emphasis is placed on the use of recombinant microorganisms. Thanks to this study, input material for 1,3-propanediol production was obtained. The biotechnological process is highly sensitive to any change and sometimes even a slight difference in culture conditions (e.g. setting of mixer blades) influences the outcome.
More significant obstacles to efficient 1,3-PDO production include 3-HPA accumulation and the inactivation of glycerol dehydratase by glycerol (Tang et al., 2009) . The latter issue could be solved effectively by using a fed-batch or continuous culture, maintaining a constant low glycerol concentration. As to the accumulation of 3-HPA, which inhibits 1,3-PDO production, it could be limited in the future by overexpressing the yqhD gene present in native E. coli. The literature reports several examples of efficient 1,3-PDO production with this approach (Tang et al., 2009) . Additional overexpression of alcohol dehydrogenase from E. coli would likely decrease 3-HPA accumulation. E. coli has a single copy of the yqhD gene; the enzyme is not highly sensitive to oxygen and is capable of utilizing the NADH and NA-DPH coenzymes. This increases the number of cofactors available for reduction (Nakamura & Whited, 2003) . In E. coli, it acts as a catalyst in reactions including the transformation of methylglyoxal to hydroxyacetone (Tang et al., 2009; Clomburg et al., 2010) . The literature shows that with additional yqhD overexpression, the efficiency of 1,3-PDO production from glycerol is typically higher than in natural producers (Zhang et al., 2005; Tang et al., 2009; Seo et al., 2010; Zhuge et al., 2010) . In regards to the concentration of methylglyoxal (which inhibits cellular growth and 1,3-PDO production), which rises significantly under anaerobic conditions, its amount could be reduced by the overexpression of glyoxalase 1 from Pseudomonas putida, as suggested by Zhu et al. (2001) .
The literature also suggests adding fumarate to stimulate the activity of anaerobic G3P dehydrogenase, and consequently, to curb G3P accumulation (which inhibits cellular growth and 1,3-PDO production), or disable the gene encoding glycerol kinase responsible for G3P production (Zhu et al. 2002) .
The final result is also affected by the cultivation temperature. Thus, a lower temperature may contribute to a more effective conversion of glycerol to 1,3-PDO, as it reduces the probability of producing heterologous enzymes in the form of inclusion bodies (Nuc et al., 2006) . Other good solutions for the industrial application of microbiological 1,3-PDO synthesis include immobilizing bacterial cells using polyurethane foams or microencapsulation. Such solutions facilitate the execution of continuous processes and the separation of the final product from biomass; they also increase cell stability and substrate tolerance, and enable the re-use of the microorganisms (Pflugmacher & Gottschalk, 1994; Zhao et al., 2006) . Data in the literature suggests that efficiency could be also increased by adding a specific mixture of ingredients enriching the growth medium, including thiamine, iron sulfate, zinc and calcium chlorides, cysteine hydrochloride (Tong et al., 1991; Tong et al., 1992) , as well as citric acid, boric acid, and manganese, cobalt, copper and iron chlorides (Ma et al., 2009; Ma et al., 2010) . These examples refer to cultures of recombinant E. coli bacteria comprising K. pneumoniae regulon genes, grown under aerobic conditions at pH 6.8.
In terms of potential changes in the method of inducing "foreign" gene expression, a glycerol-induced promoter merits consideration; this could reduce the cost, and expression would only occur during 1,3-PDO production. Another alternative is the use of a temperatureinduced λ phage promoter.
Yet another solution is the use of the E. coli rpoS promoter, which is induced by a stress factor (low pH, high or low temperature, nutrient deficiency, osmotic shock) (Liang et al., 2011) .
The E. coli Rosetta 2 (DE3)pLysS strain with the expression constructs used in the present study could also be tested in the future.
So far, chemical technology has remained the most efficient and profitable method of 1,3-PDO production. However, the biotechnological product is indisputably more desirable on the market for numerous reasons, including its low environmental impact and the reduction in mined resource consumption. Currently, some available patents describe biotechnological processes for 1,3-PDO production, but mostly from glucose. So far, Emptage et al. have attained the highest efficiency of 1,3-PDO production from glucose by a recombinant E. coli strain containing genes from S. cerevisiae and K. pneumoniae.
The results of the present study give an optimistic view of the future for biotechnological production of valuable chemicals from renewable raw materials. Implementation will be possible under two conditions: optimizing the production stage and developing an efficient process for purifying 1,3-PDO from the production medium. These stages are vital to the development of an efficient biotechnological production method for this chemical, which is the first step towards it commercialization.
